ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
네더톤 증후군 시장 규모는 향후 몇년만에 급성장할 것으로 예측됩니다. 앞으로 예측 기간의 성장은 당뇨병 발병률 증가, 인터넷 보급률 증가, 전자상거래 및 디지털 건강 플랫폼의 지속적인 증가, 층상 소양증의 유병률 증가, 희귀 질환에 대한 인식 및 지원 강화에 의해 주도될 것으로 예상됩니다.
유전자 검사의 보급이 진행되고 있는 것이 향후 네더톤 증후군 시장의 성장을 견인할 것으로 예측됩니다. 전자 검사의 보급은 유전성 질환에 대한 의식 증가와 맞춤형 의료에 대한 수요 증가에 밀려 있습니다. 그리고 적시에 치료와 맞춤형 의료를 촉진합니다. 또한 환자 관리, 유전 상담, 전반적인 결과도 개선됩니다. 예를 들어, 2023년 4월 미국 국립보건원(NIH)은 2022년 전 세계적으로 총 7만 6,326건의 유전자 검사가 수행되었으며, 7만 6,083건(99.7%)이 임상 검사였고 243건(0.3%)이 연구용이었다고 보고했습니다. 그 결과, 유전자 검사의 보급이 네더톤 증후군 시장의 성장을 견인하고 있습니다.
네더톤 증후군 시장의 각 회사는 세린 프로테아제 억제제 기반의 국소 로션과 같은 피부 장벽 기능을 개선하고 염증을 억제하기위한 고급 치료법의 개발에 주력하고 있습니다. 이 효소를 표적으로함으로써 로션은 자극과 염증을 완화시키고 과도한 염증이 피부의 불쾌감을 일으키는 네더톤 증후군과 같은 피부 상태에 완화를 가져옵니다. 예를 들어, 2024년 12월, 미국에 본사를 둔 제약 회사인 Quoin Pharmaceuticals Ltd.는 네더톤 증후군 치료제인 QRX003에 대한 새로운 임상 연구를 시작하기 위해 FDA의 허가를 받았습니다. 이 연구는 최대 8명의 환자를 대상으로 12주 동안 매일 두 번씩 신체의 80% 이상에 QRX003을 적용하여 실제 사용 환경을 모방하여 평가할 예정입니다. QRX003은 네더톤 증후군의 과도한 피부 박탈과 염증의 원인 효소인 칼리크레인을 표적으로 하는 광역 세린 프로테아제 억제제를 함유하고, 피부 장벽 기능의 개선과 증상의 경감을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 네더톤 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 네더톤 증후군 시장 : 성장률 분석
세계의 네더톤 증후군 시장 실적 : 규모와 성장(2019-2024년)
세계의 네더톤 증후군 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 네더톤 증후군 전체 시장(TAM)
제6장 시장 세분화
세계의 네더톤 증후군 시장 : 진단 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유전자 검사
신체 검사
생검 분석
세계의 네더톤 증후군 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
국소 치료
전신 치료
광선 요법
기타 치료
세계의 네더톤 증후군 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 네더톤 증후군 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
피부과 클리닉
연구기관
기타 최종 사용자
세계의 네더톤 증후군 시장 : 유전자 검사 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
SPINK5 유전자 염기서열 분석
차세대 염기서열 분석(NGS)
중합효소 연쇄반응(PCR) 검사
마이크로어레이 분석
세계의 네더톤 증후군 시장 : 신체 검사 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소양증 유사 스케일링의 임상 평가
모간 현미경 검사
아토피 피부염 증상 평가
성장 및 발달 평가
세계의 네더톤 증후군 시장 : 생검 분석 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
피부 조직 병리학
면역 조직 화학 염색
모발 및 피부 구조를 위한 전자 현미경 검사
표피 장벽 기능 검사
제7장 지역별/국가별 분석
세계의 네더톤 증후군 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 네더톤 증후군 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
네더톤 증후군 시장 : 경쟁 구도
네더톤 증후군 시장 : 기업 프로파일
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Boehringer Ingelheim International GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Daiichi Sankyo Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Evotec AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Fulgent Genetics : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Invitae Corp.
BioCryst Pharmaceuticals Inc.
GeneDx
Prevention Genetics
Blueprint Genetics Oy
Medicover Hospitals
Quoin Pharmaceuticals Ltd.
DNA Labs India
LifeMax Laboratories Inc.
Krystal Biotech Inc.
ResVita Bio
Azitra Inc
Dermelix Biotherapeutics
Sixera Pharma
MaRS Innovation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
네더톤 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
네더톤 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
네더톤 증후군 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Netherton syndrome is a rare genetic condition caused by mutations in the SPINK5 gene, resulting in red, scaly skin, brittle hair, and a heightened susceptibility to infections. This disorder affects the skin barrier and immune system, leading to chronic skin inflammation and allergic reactions.
The primary types of diagnosis for Netherton syndrome include genetic testing, physical examination, and biopsy analysis. Genetic testing examines DNA for mutations in the SPINK5 gene to confirm the presence of Netherton syndrome, facilitating early diagnosis and informed treatment decisions. Treatment options include topical treatments, systemic therapies, phototherapy, and others. These treatments are available through various distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used by different end-users, including hospitals, dermatology clinics, and research institutions.
The netherton syndrome market research report is one of a series of new reports from The Business Research Company that provides netherton syndrome market statistics, including the netherton syndrome industry global market size, regional shares, competitors with the netherton syndrome market share, detailed netherton syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the netherton syndrome industry. This netherton syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The netherton syndrome market size has grown rapidly in recent years. It will grow from $1.15 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historical period can be attributed to factors such as increased awareness of rare genetic disorders, higher healthcare spending, growing awareness of Netherton syndrome, supportive government policies, and the rise of e-commerce and digital health platforms.
The netherton syndrome market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. Looking ahead, the growth in the forecast period is expected to be driven by the increasing incidence of diabetes, greater internet penetration, the continued rise of e-commerce and digital health platforms, the growing prevalence of lamellar ichthyosis, and heightened awareness and support for rare diseases. Key trends for the forecast period include the development of targeted therapies, the expansion of clinical trials, advancements in diagnostic techniques, the adoption of telemedicine, and the growth of personalized medicine.
The increasing prevalence of genetic testing is expected to drive the growth of the Netherton syndrome market in the future. Genetic testing involves DNA analysis to identify changes, mutations, or variations linked to inherited traits, diseases, or medical conditions. The growing adoption of genetic testing is driven by greater awareness of hereditary diseases and the rising demand for personalized medicine. This surge in genetic testing enables the early and accurate diagnosis of Netherton Syndrome by detecting SPINK5 mutations, facilitating timely treatment and personalized care. It also improves patient management, genetic counseling, and overall outcomes. For instance, in April 2023, the National Institutes of Health (NIH) reported that in 2022, a total of 76,326 genetic tests were conducted worldwide, with 76,083 (99.7%) being clinical tests and 243 (0.3%) for research. As a result, the increasing prevalence of genetic testing is driving the growth of the Netherton syndrome market.
Companies in the Netherton syndrome market are focusing on developing advanced treatments, such as serine protease inhibitor-based topical lotions, to improve skin barrier function and reduce inflammation. These lotions are designed to block the action of serine proteases, enzymes involved in inflammation and immune response. By targeting these enzymes, the lotions help alleviate irritation and inflammation, providing relief for skin conditions such as Netherton Syndrome, where excessive inflammation causes skin discomfort. For example, in December 2024, Quoin Pharmaceuticals Ltd., a U.S.-based pharmaceutical company, received FDA clearance to begin a new clinical study for QRX003, a treatment for Netherton Syndrome. This study will evaluate up to eight patients applying QRX003 twice daily to over 80% of their body for 12 weeks, mimicking real-world use. QRX003 contains a broad-spectrum serine protease inhibitor targeting kallikreins, enzymes responsible for excessive skin shedding and inflammation in Netherton Syndrome, aiming to improve skin barrier function and reduce symptoms.
In July 2023, FarmaMondo Group, a Switzerland-based pharmaceutical company, partnered with Quoin Pharmaceuticals Inc. to commercialize QRX003 for Netherton syndrome in Singapore. This partnership aims to expand market access for QRX003, an innovative therapy currently in clinical development, providing new treatment options for patients with this rare condition. Quoin Pharmaceuticals Inc. is an Israel-based company developing potential therapies for Netherton syndrome.
Major players in the netherton syndrome market are Novartis AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Evotec AG, Fulgent Genetics, Invitae Corp., BioCryst Pharmaceuticals Inc., GeneDx, Prevention Genetics, Blueprint Genetics Oy, Medicover Hospitals, Quoin Pharmaceuticals Ltd., DNA Labs India, LifeMax Laboratories Inc., Krystal Biotech Inc., ResVita Bio, Azitra Inc, Dermelix Biotherapeutics, Sixera Pharma, MaRS Innovation.
North America was the largest region in the netherton syndrome market in 2024. The regions covered in netherton syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the netherton syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The netherton syndrome market consists of revenues earned by entities by providing services such as genetic testing, personalized treatment plans, genetic counseling services, medical treatments, and patient care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The netherton syndrome market includes sales of immunosuppressive drugs, oral medications, and genetic testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Netherton Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on netherton syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for netherton syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The netherton syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Physical Examination: Clinical Assessment Of Ichthyosis-like Scaling; Hair Shaft Microscopy; Evaluation Of Atopic Dermatitis Symptoms; Growth and Developmental Assessment
3) By Biopsy Analysis: Skin Histopathology; Immunohistochemical Staining; Electron Microscopy For Hair And Skin Structure; Epidermal Barrier Function Testing
Companies Mentioned: Novartis AG; Boehringer Ingelheim International GmbH; Daiichi Sankyo Company Limited; Evotec AG; Fulgent Genetics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Netherton Syndrome Market Characteristics
3. Netherton Syndrome Market Trends And Strategies
4. Netherton Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Netherton Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Netherton Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Netherton Syndrome Market Growth Rate Analysis
5.4. Global Netherton Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Netherton Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Netherton Syndrome Total Addressable Market (TAM)
6. Netherton Syndrome Market Segmentation
6.1. Global Netherton Syndrome Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Physical Examination
Biopsy Analysis
6.2. Global Netherton Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Treatments
Systemic Treatments
Phototherapy
Other Treatments
6.3. Global Netherton Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Netherton Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Dermatology Clinics
Research Institutes
Other End-Users
6.5. Global Netherton Syndrome Market, Sub-Segmentation Of Genetic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
SPINK5 Gene Sequencing
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR) Testing
Microarray Analysis
6.6. Global Netherton Syndrome Market, Sub-Segmentation Of Physical Examination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Assessment Of Ichthyosis-like Scaling
Hair Shaft Microscopy
Evaluation Of Atopic Dermatitis Symptoms
Growth and Developmental Assessment
6.7. Global Netherton Syndrome Market, Sub-Segmentation Of Biopsy Analysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Histopathology
Immunohistochemical Staining
Electron Microscopy For Hair And Skin Structure
Epidermal Barrier Function Testing
7. Netherton Syndrome Market Regional And Country Analysis
7.1. Global Netherton Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Netherton Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
